Table 1. Clinical characteristics of 15 patients with hepatitis E virus–linked neurologic disorders, France, January 2006–June 2013*.

Patient no.	Neurologic pathology	Age, y/sex	Treatment	Other symptoms	Neurologic symptoms at last follow-up	Follow up times, wk
1	MM	59/M	None	Asthenia	No	10
2	MM	44/F	None	Fever, asthenia, arthromyalgia	Yes	4
3	MM	65/M	Corticosteroids	Asthenia	No	157
4	MM	25/F	None	None	No	33
5	MM	49/M	None	None	No	NA
6	MM	77/F	RBV	None	No	44
7	PTS	51/M	RBV + IVIg	Arthromyalgia, asthenia	No	100
8	PTS	55/F	None	Asthenia, arthromyalgia	Yes	126
9	PTS	56/M	None	Asthenia	Yes	42
10	PTS	56/M	RBV + IVIg	Asthenia	Yes	16
11	MR	74/M	IV Ig	Arthromyalgia, asthenia	No	77
12	MR	54/F	None	Fever, nausea	No	NA
13	MR	33/F	None	Fever, arthromyalgia	No	161
14	GBS	60/F	IV Ig	Asthenia, acute low back pain	Yes	5
15	MFS	54/M	IV Ig	Asthenia, anorexia	Yes	13

*MM, mononeuritis multiplex; PTS, Parsonnage-Turner syndrome; MR, meningoradiculitis; GBS, Guillain–Barré syndrome; MFS, Miller-Fisher syndrome; RBV, ribavirin; IVIg, intravenous immunoglobulin; NA, not available.